Medical Instruments Encyclopedia
Home > Medical Instruments Encyclopedia
CEA/CA15-3 Detection Kit (Flow Fluorescence Luminescence Method)
The CEA/CA15-3 Detection Kit is composed of three main components: Component A (Capture Microsphere Suspension), Component B (Fluorescently Labeled Antibody), and Component C (Calibrator). Component A includes magnetic microspheres coated with anti-CEA and anti-CA15-3 monoclonal antibodies, buffer, bovine serum albumin, and preservatives. Component B contains R-PE labeled anti-CEA and anti-CA15-3 monoclonal antibodies, buffer, bovine serum albumin, and preservatives. Component C consists of CEA and CA15-3 antigens, buffer, bovine serum albumin, and preservatives.
Product English Name:
CEA/CA15-3 Detection Kit (Flow Fluorescence Luminescence Method)
Alias:
Tumor Marker Detection Kit,CEA/CA15-3 Assay Kit
Intended Use:
This kit is designed for the quantitative detection of carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3) in human serum samples. It is primarily used for monitoring tumor treatment efficacy, prognosis evaluation, and recurrence surveillance.
Product Introduction

The CEA/CA15-3 Detection Kit is a state-of-the-art diagnostic tool designed for the precise measurement of tumor markers in human serum. Utilizing flow fluorescence luminescence technology, this kit offers high sensitivity and specificity, making it an essential tool in oncology diagnostics. It is widely used in clinical settings to monitor cancer treatment progress and predict patient outcomes.

1. The kit features advanced flow fluorescence luminescence technology, ensuring high accuracy and reliability in detecting tumor markers. Its innovative design allows for rapid and efficient analysis, making it a preferred choice for clinical laboratories.
2. The kit is composed of three key components: Capture Microsphere Suspension, Fluorescently Labeled Antibody, and Calibrator. Each component is meticulously formulated to ensure optimal performance and stability during the detection process.
3. The primary use of this kit is to quantitatively detect CEA and CA15-3 levels in human serum. It plays a crucial role in monitoring tumor treatment efficacy, assessing prognosis, and detecting potential recurrence, thereby aiding in personalized cancer management.

The CEA/CA15-3 Detection Kit, also known as the Tumor Marker Detection Kit, is a vital tool in modern oncology. Its advanced technology and precise composition make it indispensable for monitoring cancer treatment and patient outcomes. This kit is a testament to the advancements in diagnostic medicine, offering hope and clarity to both patients and healthcare providers.

Main Features

The CEA/CA15-3 Detection Kit offers high sensitivity and specificity in detecting tumor markers, making it an essential tool for cancer diagnostics and monitoring.

1. High Sensitivity: The kit is designed to detect even low concentrations of CEA and CA15-3, ensuring accurate results in early-stage cancer detection.
2. Specificity: The use of monoclonal antibodies ensures that the kit specifically targets CEA and CA15-3, minimizing cross-reactivity with other antigens.
3. Rapid Analysis: The flow fluorescence luminescence method allows for quick and efficient analysis, reducing the time required for diagnosis.
4. Stability: The components of the kit are formulated to maintain stability over a wide range of storage conditions, ensuring reliable performance.
5. User-Friendly: The kit is designed for ease of use, with clear instructions and minimal preparation required, making it accessible to a wide range of laboratory settings.

The CEA/CA15-3 Detection Kit stands out for its high sensitivity, specificity, and rapid analysis capabilities. Its stability and user-friendly design make it a reliable choice for clinical laboratories, aiding in the effective management of cancer patients.

Clinical Applications

The CEA/CA15-3 Detection Kit is widely used in clinical settings for monitoring cancer treatment efficacy, prognosis evaluation, and recurrence surveillance.

1. Treatment Monitoring: The kit is used to monitor the effectiveness of cancer treatments by tracking changes in CEA and CA15-3 levels over time.
2. Prognosis Evaluation: By measuring tumor marker levels, the kit helps clinicians assess the likely course of the disease and predict patient outcomes.
3. Recurrence Surveillance: The kit is employed to detect early signs of cancer recurrence, allowing for timely intervention and treatment.
4. Personalized Medicine: The kit aids in tailoring treatment plans based on individual patient responses, enhancing the effectiveness of cancer therapies.
5. Research Applications: Beyond clinical use, the kit is also utilized in cancer research to study tumor marker dynamics and develop new diagnostic and therapeutic strategies.

The CEA/CA15-3 Detection Kit is a cornerstone in clinical oncology, providing critical insights into cancer treatment efficacy, prognosis, and recurrence. Its applications extend beyond routine diagnostics, contributing to the advancement of personalized medicine and cancer research.

Purchasing Guide

When purchasing the CEA/CA15-3 Detection Kit, consider product specifications, types, budget, and intended use to ensure optimal selection and application.

1. Product Specifications: Evaluate the kit's sensitivity, specificity, and stability to ensure it meets your laboratory's diagnostic needs.
2. Product Types: Choose between different kit formats, such as single-use or multi-use, based on your laboratory's workflow and volume of tests.
3. Budget Considerations: Assess the cost-effectiveness of the kit, considering both the initial purchase price and long-term operational costs.
4. Usage Scenarios: Determine the specific clinical or research applications for which the kit will be used, ensuring it aligns with your objectives and requirements.

Selecting the right CEA/CA15-3 Detection Kit involves careful consideration of product specifications, types, budget, and intended use. By aligning these factors with your laboratory's needs, you can ensure optimal performance and value from your investment.

 Precautions

Proper handling and storage of the CEA/CA15-3 Detection Kit are essential to ensure accurate results and maintain kit integrity.

1. Storage Conditions: Store the kit at the recommended temperature to preserve the stability and performance of its components.
2. Handling Procedures: Follow the manufacturer's instructions for handling the kit to avoid contamination and ensure accurate results.
3. Expiration Date: Always check the expiration date before use to ensure the kit's components are still effective.
4. Quality Control: Regularly perform quality control tests to verify the kit's performance and reliability.
5. Disposal: Dispose of used kit components according to local regulations and laboratory safety protocols to minimize environmental impact.

The CEA/CA15-3 Detection Kit requires careful attention to storage, handling, and quality control to maintain its effectiveness. By adhering to these precautions, you can ensure reliable results and prolong the kit's usability, ultimately supporting accurate cancer diagnostics and patient care.

Easy procurement

We have the latest medical device product database in China, which can quickly meet your procurement needs.

Submit your purchase list, and we will reply to your inquiry within half an hour at the earliest.

Quickly respond to your procurement needs:
Upload your purchase list
Support EXCEL/PDF/Word/compressed files